Research suggested that gut microbiota may participate in the plasticity of CD4+ T cells in the tumor microenvironment and cause antitumor or tumor-promoting immune responses, thereby exerting anticancer or tumor-promoting effects (39), but the specific signature bacteria that related to the immune function in the breast cancer patients are rarely reported. This evidence concerns the gene CD4 and breast cancer.